Truscreen Group Ltd
ASX:TRU
Truscreen Group Ltd
ASX:TRU
Price:
0.016
AUD
14.29%
Market Closed
Market Cap:
AU$8.8m
Relative Value
The Relative Value of one
TRU
stock under the Base Case scenario is
0.009
AUD.
Compared to the current market price of 0.016 AUD,
Truscreen Group Ltd
is
Overvalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRU
Relative Value
Base Case
0.009
AUD
Overvaluation 43%
Multiples Across Competitors
TRU Competitors Multiples
Truscreen Group Ltd Competitors
Truscreen Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NZ |
|
Truscreen Group Ltd
ASX:TRU
|
13.5m AUD | 8.7 | -5.4 | -4.7 | -4.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.3 | 16.8 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175B USD | 17.4 | 61.3 | 46.5 | 57.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 3.2 | 24.8 | 13.6 | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.3B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.2B EUR | 1.9 | 21 | 11.6 | 16.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.2 | 46.1 | 25.4 | 27.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.9B USD | 11.1 | 45.2 | 32.1 | 35.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.5B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
35B USD | 6.5 | 23.5 | 16.6 | 18.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
